Fudan University Researchers Yield New Study Findings on Ovarian Cancer (A durable response to programmed cell death 1 blockade in a multidrug-resistant recurrent ovarian cancer patient with HLA-B44 supertype: A case report)

Source :: Women's Health Weekly. October 27, 2022, 126
Publication Year :: 2022
Abstract: 2022 OCT 27 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Researchers detail new data in ovarian cancer. According to news reporting out of Shanghai, [...]

Subjects :: Oncology, Experimental
Biochemistry -- Research
Diseases -- Relapse
Drug resistance in microorganisms -- Research -- Care and treatment
Cancer -- Care and treatment -- Research
Apoptosis -- Research
Ovarian cancer -- Research -- Care and treatment
Health
Women's issues/gender studies
Fudan University

Tools